Back to Search
Start Over
MR1-dependence of unmetabolized folic acid side-effects.
- Source :
-
Frontiers in immunology [Front Immunol] 2022 Aug 09; Vol. 13, pp. 946713. Date of Electronic Publication: 2022 Aug 09 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- The fortification of flour with folic acid for the prevention of neural tube defects (NTD) is currently mandated in over eighty countries worldwide, hence compelling its consumption by the greater part of the world's population. Notwithstanding its beneficial impact on rates of NTD, pervasive folic acid supplementation has invariably led to additive daily intakes reaching well beyond their original target, resulting in the circulation of unmetabolized folic acid. Associated idiopathic side-effects ranging from allergies to cancer have been suggested, albeit inconclusively. Herein, we hypothesize that their inconsistent detection and elusive etiology are linked to the in vivo generation of the immunosuppressive folic acid metabolite 6-formylpterin, which interferes with the still emerging and varied functions of Major Histocompatibility Complex-related molecule 1 (MR1)-restricted T cells. Accordingly, we predict that fortification-related adverse health outcomes can be eliminated by substituting folic acid with the bioequivalent folate vitamer 5-methyltetrahydrofolate, which does not break down into 6-formylpterin.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Tang, Cait, White, Arabshahi, O’Sullivan and Gasser.)
- Subjects :
- Flour
Folic Acid adverse effects
Food, Fortified adverse effects
Histocompatibility Antigens Class I
Humans
Minor Histocompatibility Antigens
Drug-Related Side Effects and Adverse Reactions
Neural Tube Defects chemically induced
Neural Tube Defects epidemiology
Neural Tube Defects prevention & control
Subjects
Details
- Language :
- English
- ISSN :
- 1664-3224
- Volume :
- 13
- Database :
- MEDLINE
- Journal :
- Frontiers in immunology
- Publication Type :
- Academic Journal
- Accession number :
- 36016938
- Full Text :
- https://doi.org/10.3389/fimmu.2022.946713